Evidence map›Paper›PMID 38031949›Full record

ArticleTurkish journal of medical sciences2023

Retrospective analysis of children diagnosed with Kawasaki disease.

Fatih Varol, Reyhan Dedeoğlu, Aziz Kiliç, Murat Tuğberk Bakar, Amra Adrovic, Sezgin Şahin, Mehmet Yildiz, Kenan Barut, Halit Çam, Özgür Kasapçopur

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Fatih VarolDepartment of Pediatric Intensive Care, University of Health Science Sancaktepe Şehit Profesör Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkiye.
Reyhan DedeoğluDepartment of Pediatric Cardiology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Aziz KiliçDepartment of Pediatrics, Faculty of Medicine, Ankara University, Ankara, Turkiye.
Murat Tuğberk BakarDepartment of Public Health, Medical School, Marmara University, İstanbul, Turkiye.
Amra AdrovicDepartment of Pediatric Rheumatology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Sezgin ŞahinDepartment of Pediatric Rheumatology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Mehmet YildizDepartment of Pediatric Rheumatology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Kenan BarutDepartment of Pediatric Rheumatology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Halit ÇamDepartment of Pediatric Intensive Care, University of Health Science Sancaktepe Şehit Profesör Dr. İlhan Varank Training and Research Hospital, İstanbul, Turkiye.
Özgür KasapçopurDepartment of Pediatric Rheumatology, Cerrahpaşa Medical School, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
Istanbul University-Cerrahpaşa · TRUniversity of Health Sciences Antigua · AGAnkara University · TRMarmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of our study was to evaluate the long-term impacts of Kawasaki disease on our patients regarding coronary involvement demographic characteristics, treatment regimens, and clinical course.

methodsOur study included 104 patients diagnosed and hospitalized with Kawasaki disease in our center, from January 2004 to January 2019. In our study, patients were divided into three groups according to coronary artery involvement. Patients in group 1 had no echocardiographic findings, while the ones in group 2 had coronary artery dilatation and ones in group 3 had coronary artery aneurysm (CAA).

resultsAmong 104 patients, the median age was 9.15 (3.0-22.0) years, and 61 of the patients were male while 43 of the patients were female. With a wide range of 1.50-16.50 years of follow-up time, the median diagnosis age of our patients was 31 months (3.0-164.0). Fever duration (median day 10 (5-21), p = 0.025) was statistically significantly higher in group 3. Blood C-reactive protein (CRP) levels, white blood cell (WBC) counts, and neutrophil counts were significantly higher in group 3. There was a statistically significant difference between patients in group 3 and group 2 in which the lowest strain deformation values were in the patients of group 3. In contrast to group 1, the time for initiation of IVIG therapy is significantly prolonged both in group 2 (median: 9.5 days, p = 0.028) and group 3 (median: 10 days, p = 0.036). DISCUSSION: In our study, serum CRP levels, WBC count, and neutrophil count were higher in patients with coronary artery abnormalities, in agreement with the previous studies. In the light of our results, we consider that the most important determining factor for the development of coronary artery aneurysm is the time of intravenous immunoglobulin (IVIG) administration.

Indexed as

Coronary AneurysmCoronary Artery DiseaseMucocutaneous Lymph Node SyndromeChildChild, PreschoolFemaleHumansImmunoglobulins, IntravenousInfantMaleRetrospective StudiesImmunoglobulins, Intravenouscoronary aneurysmintravenous immunoglobulinKawasaki

Identifiers

PMID38031949
PMCPMC10760559
OpenAlexW4386069672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.